Infection News

VIENNA — In this exclusive video from the International Liver Congress 2019, Heather Valerio, from the Kirby Institute at the University of New South Wales in Australia, provides an overview of the Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage study of hepatitis C outcomes among people who inject drugs.

A recent case-control study identified antibiotic use as a risk factor for community-associated Clostridioides difficile infection, or CA-CDI, in children.

VIENNA — In this exclusive video from the International Liver Congress 2019, Marc Bulterys, MD, PhD, team leader of the Global Hepatitis Program at the World Health Organization in Geneva, Switzerland, discusses the prevention, care and treatment of hepatitis B and hepatitis C among children and adolescents.

VIENNA — In the face of the remaining gaps in the hepatitis C care cascade, timely screening, monitoring and linkage to care by general practitioners coupled with early treatment by specialists could effectively reduce the hepatic and extrahepatic burden of the virus, according to a real-world analysis presented at the International Liver Congress 2019.

VIENNA — Patients with hepatitis C genotype 3 and compensated cirrhosis had higher rates of sustained virologic response after treatment with Epclusa and ribavirin than with Epclusa alone or combined Sovaldi and Daklinza with ribavirin.

A multistate outbreak of Salmonella Carrau infection has been linked to pre-cut melons from Caito Foods.

Findings of a prospective birth cohort study presented at the European Congress of Clinical Microbiology & Infectious Diseases suggested that infants born through caesarean section have an altered gut microbiota that may leave them more susceptible to respiratory infections in the first year of life.

Health officials linked a multistate outbreak of Escherichia coli to ground beef, although no common supplier, distributor or brand has yet been identified.

VIENNA — A combination of a core protein inhibitor and nucleos(t)ide analogue therapy brought hepatitis B virus RNA and DNA below levels of quantification, pointing toward the possibility of a cure, according to a presenter at the International Liver Congress.

VIENNA — A combination of Myrcludex with interferon produced undetectable levels of hepatitis D and significant lowering of hepatitis B virus, according to data presented during the International Liver Congress 2019.